Ozmosi | Sorbitan tristearate Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

Sorbitan tristearate

Alternative Names: sorbitan tristearate
Clinical Status: Inactive
Latest Update: 2025-06-15
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Large Molecule

Route of Administration: Subcutaneous, Topical

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: University of Auckland
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

ACTRN12619000390189

ACTRN12619000390189

N/A

Recruiting

Keratoconjunctivitis Sicca|Dry Eye Disease

2019-10-30

2024-08-29

Treatments

ACTRN12625000294459

ACTRN12625000294459

N/A

Not yet recruiting

Keratoconjunctivitis Sicca|Dry Eye Disease

None

2025-07-26

Treatments

ACTRN12619000361101

ACTRN12619000361101

N/A

Recruiting

Keratoconjunctivitis Sicca|Dry Eye Disease

None

2024-08-29

Treatments